Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pulmonary disease

BACKGROUND AND OBJECTIVE: Among patients with chronic obstructive pulmonary disease (COPD), diabetes mellitus (DM) is a common comorbidity and is probably associated with increased systemic inflammation and worse prognosis. Metformin, with its pleiotropic anti-inflammatory and antioxidant actions, m...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Te-Wei, Huang, Chun-Ta, Tsai, Yi-Ju, Lien, Angela Shin-Yu, Lai, Feipei, Yu, Chong-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451256/
https://www.ncbi.nlm.nih.gov/pubmed/30953517
http://dx.doi.org/10.1186/s12931-019-1035-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451256/
https://www.ncbi.nlm.nih.gov/pubmed/30953517
http://dx.doi.org/10.1186/s12931-019-1035-9

Ejemplares similares